Account
Inquiry
QSC Tirzepatide (LY3437943) is a novel triple agonist peptide that simultaneously targets glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCGR) receptors. This innovative compound has shown promising results in clinical studies for weight management applications.
The qsc tirzepatide peptide works through multiple mechanisms: enhancing insulin secretion, suppressing glucagon release, delaying gastric emptying, and promoting satiety. Its triple-action approach makes it particularly effective for metabolic research applications.
Our qsc tirzepatide is supplied as a white lyophilized powder with minimum 99% purity by HPLC analysis. The product undergoes rigorous quality control testing including mass spectrometry verification to ensure batch-to-batch consistency.
As a research chemical, qsc tirzepatide is intended for laboratory use only. This product is not for human consumption and should only be handled by qualified researchers in controlled laboratory settings.
The peptide demonstrates excellent stability when stored properly at 2-8°C in lyophilized form. For long-term storage, we recommend keeping the product in a desiccated environment at -20°C.
